Patent · US Active

Treatment of Clostridium difficile infection

US10064904B2 · kind B2 · utility

13Cited by

3References

12Claims

0Family size

Assignee

Vedanta Biosciences, Inc. · US

Inventors

Jessica Schneider · Cambridge, US
Yun-Gi Kim · Watertown, US
Bernat Olle · Cambridge, US
Shilpa Reddy · Watertown, US
Jason Norman · Weymouth, US
Juan Patarroyo · Lexington, US

Key dates

Filing date	Jan 30, 2018
Grant date	Sep 4, 2018
Priority date	—
Expiry date	Jan 30, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/0031
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are compositions and methods for the treatment or prevention of pathogenic infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.